Greece
· Delayed Price · Currency is EUR Biokarpet Statistics
Total Valuation
Biokarpet has a market cap or net worth of EUR 40.78 million. The enterprise value is 146.03 million.
| Market Cap | 40.78M |
| Enterprise Value | 146.03M |
Important Dates
The next estimated earnings date is Friday, September 26, 2025.
| Earnings Date | Sep 26, 2025 |
| Ex-Dividend Date | Aug 26, 2024 |
Share Statistics
Biokarpet has 23.99 million shares outstanding.
| Current Share Class | 23.99M |
| Shares Outstanding | 23.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.01% |
| Owned by Institutions (%) | 10.94% |
| Float | 14.39M |
Valuation Ratios
The trailing PE ratio is 134.82.
| PE Ratio | 134.82 |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.03, with an EV/FCF ratio of -31.08.
| EV / Earnings | 482.82 |
| EV / Sales | 0.71 |
| EV / EBITDA | 12.03 |
| EV / EBIT | 27.31 |
| EV / FCF | -31.08 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 2.31.
| Current Ratio | 1.94 |
| Quick Ratio | 1.09 |
| Debt / Equity | 2.31 |
| Debt / EBITDA | 9.31 |
| Debt / FCF | -24.05 |
| Interest Coverage | 0.80 |
Financial Efficiency
Return on equity (ROE) is 0.63% and return on invested capital (ROIC) is 2.11%.
| Return on Equity (ROE) | 0.63% |
| Return on Assets (ROA) | 1.67% |
| Return on Invested Capital (ROIC) | 2.11% |
| Return on Capital Employed (ROCE) | 3.49% |
| Revenue Per Employee | 313,727 |
| Profits Per Employee | 462 |
| Employee Count | 655 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 4.41 |
Taxes
In the past 12 months, Biokarpet has paid 771,514 in taxes.
| Income Tax | 771,514 |
| Effective Tax Rate | 71.43% |
Stock Price Statistics
The stock price has decreased by -29.84% in the last 52 weeks. The beta is 0.47, so Biokarpet's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -29.84% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 50.06 |
| Average Volume (20 Days) | 16,107 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biokarpet had revenue of EUR 205.49 million and earned 302,451 in profits. Earnings per share was 0.01.
| Revenue | 205.49M |
| Gross Profit | 31.37M |
| Operating Income | 5.35M |
| Pretax Income | 1.08M |
| Net Income | 302,451 |
| EBITDA | 10.68M |
| EBIT | 5.35M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 8.52 million in cash and 112.99 million in debt, giving a net cash position of -104.47 million or -4.36 per share.
| Cash & Cash Equivalents | 8.52M |
| Total Debt | 112.99M |
| Net Cash | -104.47M |
| Net Cash Per Share | -4.36 |
| Equity (Book Value) | 48.89M |
| Book Value Per Share | 2.01 |
| Working Capital | 48.09M |
Cash Flow
In the last 12 months, operating cash flow was 10.98 million and capital expenditures -15.67 million, giving a free cash flow of -4.70 million.
| Operating Cash Flow | 10.98M |
| Capital Expenditures | -15.67M |
| Free Cash Flow | -4.70M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 15.26%, with operating and profit margins of 2.60% and 0.15%.
| Gross Margin | 15.26% |
| Operating Margin | 2.60% |
| Pretax Margin | 0.53% |
| Profit Margin | 0.15% |
| EBITDA Margin | 5.20% |
| EBIT Margin | 2.60% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.15%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 1.15% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.15% |
| Earnings Yield | 0.74% |
| FCF Yield | -11.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Mar 15, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Biokarpet has an Altman Z-Score of 1.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 4 |